Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China
· Delayed Price · Currency is CNY 7.51
+0.20 (2.74%)
Apr 30, 2026, 11:54 AM CST
SHE:002349 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,460 | 1,388 | 1,496 | 1,550 | 1,336 | Upgrade
|
| Other Revenue | - | 13.63 | 15.41 | 22.58 | 21.41 | Upgrade
|
| Revenue | 1,460 | 1,402 | 1,512 | 1,573 | 1,358 | Upgrade
|
| Revenue Growth (YoY) | 4.13% | -7.25% | -3.90% | 15.85% | 5.97% | Upgrade
|
| Cost of Revenue | 702.4 | 719.73 | 781.18 | 847.06 | 739.21 | Upgrade
|
| Gross Profit | 757.56 | 682.36 | 730.58 | 726 | 618.66 | Upgrade
|
| Selling, General & Admin | 394.33 | 366.72 | 346.78 | 401.01 | 352.64 | Upgrade
|
| Research & Development | 64.99 | 61.79 | 64.62 | 86.98 | 74.76 | Upgrade
|
| Other Operating Expenses | 13.88 | 17.48 | 17.77 | 22.39 | 20.17 | Upgrade
|
| Operating Expenses | 473.65 | 449.36 | 431.89 | 514.64 | 462.16 | Upgrade
|
| Operating Income | 283.91 | 233 | 298.69 | 211.36 | 156.51 | Upgrade
|
| Interest Expense | -0.57 | -1.34 | -2.57 | -6.79 | -12.94 | Upgrade
|
| Interest & Investment Income | 30.3 | 48.38 | 23.87 | 39.71 | 14.16 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.34 | 2.35 | 6.86 | -1.48 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.44 | -0.3 | 0.43 | -1.24 | 1.45 | Upgrade
|
| EBT Excluding Unusual Items | 310.19 | 282.09 | 322.76 | 249.9 | 157.7 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.17 | 3.82 | 6.83 | 4.99 | 31.44 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.2 | -0.09 | -0.06 | -0.58 | Upgrade
|
| Asset Writedown | -10.75 | -2.13 | -4.52 | -16.96 | -16.7 | Upgrade
|
| Other Unusual Items | - | 9.75 | 4.71 | 12.34 | 7.03 | Upgrade
|
| Pretax Income | 303.61 | 293.32 | 329.7 | 250.21 | 178.89 | Upgrade
|
| Income Tax Expense | 41.77 | 45.85 | 53.23 | 37.92 | 38.93 | Upgrade
|
| Earnings From Continuing Operations | 261.84 | 247.47 | 276.47 | 212.29 | 139.96 | Upgrade
|
| Minority Interest in Earnings | -42.55 | -34.81 | -28.77 | -0.06 | 20.74 | Upgrade
|
| Net Income | 219.28 | 212.65 | 247.7 | 212.23 | 160.7 | Upgrade
|
| Net Income to Common | 219.28 | 212.65 | 247.7 | 212.23 | 160.7 | Upgrade
|
| Net Income Growth | 3.12% | -14.15% | 16.71% | 32.06% | 44.79% | Upgrade
|
| Shares Outstanding (Basic) | 819 | 814 | 814 | 814 | 814 | Upgrade
|
| Shares Outstanding (Diluted) | 819 | 814 | 814 | 814 | 814 | Upgrade
|
| Shares Change (YoY) | 0.58% | -0.01% | 0.02% | -0.00% | -0.03% | Upgrade
|
| EPS (Basic) | 0.27 | 0.26 | 0.30 | 0.26 | 0.20 | Upgrade
|
| EPS (Diluted) | 0.27 | 0.26 | 0.30 | 0.26 | 0.20 | Upgrade
|
| EPS Growth | 2.53% | -14.13% | 16.69% | 32.07% | 44.83% | Upgrade
|
| Free Cash Flow | 320.54 | 280.1 | 262.93 | 296.8 | 225.02 | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.34 | 0.32 | 0.36 | 0.28 | Upgrade
|
| Dividend Per Share | - | 0.079 | 0.092 | 0.080 | 0.060 | Upgrade
|
| Dividend Growth | - | -14.67% | 15.00% | 33.33% | 46.34% | Upgrade
|
| Gross Margin | 51.89% | 48.67% | 48.33% | 46.15% | 45.56% | Upgrade
|
| Operating Margin | 19.45% | 16.62% | 19.76% | 13.44% | 11.53% | Upgrade
|
| Profit Margin | 15.02% | 15.17% | 16.38% | 13.49% | 11.83% | Upgrade
|
| Free Cash Flow Margin | 21.96% | 19.98% | 17.39% | 18.87% | 16.57% | Upgrade
|
| EBITDA | 363.51 | 307.95 | 382.89 | 319.43 | 257.8 | Upgrade
|
| EBITDA Margin | 24.90% | 21.96% | 25.33% | 20.31% | 18.99% | Upgrade
|
| D&A For EBITDA | 79.6 | 74.94 | 84.21 | 108.07 | 101.29 | Upgrade
|
| EBIT | 283.91 | 233 | 298.69 | 211.36 | 156.51 | Upgrade
|
| EBIT Margin | 19.45% | 16.62% | 19.76% | 13.44% | 11.53% | Upgrade
|
| Effective Tax Rate | 13.76% | 15.63% | 16.14% | 15.16% | 21.76% | Upgrade
|
| Revenue as Reported | 1,460 | 1,402 | 1,512 | 1,573 | 1,358 | Upgrade
|
| Advertising Expenses | - | 13.69 | 13.65 | 7.27 | 11.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.